ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.

Sarah R Verhoeff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.